isoproterenol has been researched along with Dyslipidemia in 6 studies
Isoproterenol: Isopropyl analog of EPINEPHRINE; beta-sympathomimetic that acts on the heart, bronchi, skeletal muscle, alimentary tract, etc. It is used mainly as bronchodilator and heart stimulant.
isoprenaline : A secondary amino compound that is noradrenaline in which one of the hydrogens attached to the nitrogen is replaced by an isopropyl group. A sympathomimetic acting almost exclusively on beta-adrenergic receptors, it is used (mainly as the hydrochloride salt) as a bronghodilator and heart stimulant for the management of a variety of cardiac disorders.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study evaluates the protective effects of 7-hydroxycoumarin (7-HC) on dyslipidemia and cardiac hypertrophy in isoproterenol (ISO) induced myocardial infarction (MI) in rats." | 7.83 | Protective Effects of 7-Hydroxycoumarin on Dyslipidemia and Cardiac Hypertrophy in Isoproterenol-Induced Myocardial Infarction in Rats. ( Jagadeesh, GS; Nagoor Meeran, MF; Selvaraj, P, 2016) |
| " This study aims to evaluate the protective effects of sinapic acid on cardiac hypertrophy, dyslipidaemia and alterations in lipoproteins and electrocardiogram in isoproterenol-induced myocardial infarcted rats." | 7.79 | Protective effects of sinapic acid on cardiac hypertrophy, dyslipidaemia and altered electrocardiogram in isoproterenol-induced myocardial infarcted rats. ( Mainzen Prince, PS; Roy, SJ, 2013) |
| "Although spironolactone and telmisartan are reported to reduce the risk of morbidity and death, direct studies on their effects on isoproterenol-induced cardiac hypertrophy are scanty." | 7.78 | Beneficial role of spironolactone, telmisartan and their combination on isoproterenol-induced cardiac hypertrophy. ( Goyal, BR; Mehta, AA, 2012) |
| "This study evaluates the protective effects of 7-hydroxycoumarin (7-HC) on dyslipidemia and cardiac hypertrophy in isoproterenol (ISO) induced myocardial infarction (MI) in rats." | 3.83 | Protective Effects of 7-Hydroxycoumarin on Dyslipidemia and Cardiac Hypertrophy in Isoproterenol-Induced Myocardial Infarction in Rats. ( Jagadeesh, GS; Nagoor Meeran, MF; Selvaraj, P, 2016) |
| " This study aims to evaluate the protective effects of sinapic acid on cardiac hypertrophy, dyslipidaemia and alterations in lipoproteins and electrocardiogram in isoproterenol-induced myocardial infarcted rats." | 3.79 | Protective effects of sinapic acid on cardiac hypertrophy, dyslipidaemia and altered electrocardiogram in isoproterenol-induced myocardial infarcted rats. ( Mainzen Prince, PS; Roy, SJ, 2013) |
| "Although spironolactone and telmisartan are reported to reduce the risk of morbidity and death, direct studies on their effects on isoproterenol-induced cardiac hypertrophy are scanty." | 3.78 | Beneficial role of spironolactone, telmisartan and their combination on isoproterenol-induced cardiac hypertrophy. ( Goyal, BR; Mehta, AA, 2012) |
| "Dyslipidemia is an important factor in MetS and is related to atrial fibrillation (AF)." | 1.43 | VLDL from Metabolic Syndrome Individuals Enhanced Lipid Accumulation in Atria with Association of Susceptibility to Atrial Fibrillation. ( Chen, CH; Chu, CS; Hsiao, YL; Ke, LY; Lai, WT; Lee, HC; Lin, HT; Sheu, SH; Shin, SJ; Wei, C; Wu, BN, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Al-Rasheed, NM | 2 |
| Attia, HA | 1 |
| Mohamed, RA | 1 |
| Al-Amin, MA | 1 |
| Lee, HC | 1 |
| Lin, HT | 1 |
| Ke, LY | 1 |
| Wei, C | 1 |
| Hsiao, YL | 1 |
| Chu, CS | 1 |
| Lai, WT | 1 |
| Shin, SJ | 1 |
| Chen, CH | 1 |
| Sheu, SH | 1 |
| Wu, BN | 1 |
| Jagadeesh, GS | 1 |
| Nagoor Meeran, MF | 1 |
| Selvaraj, P | 1 |
| Selenscig, D | 1 |
| Rossi, A | 1 |
| Chicco, A | 1 |
| Lombardo, YB | 1 |
| Goyal, BR | 1 |
| Mehta, AA | 1 |
| Roy, SJ | 1 |
| Mainzen Prince, PS | 1 |
6 other studies available for isoproterenol and Dyslipidemia
| Article | Year |
|---|---|
Preventive effects of selenium yeast, chromium picolinate, zinc sulfate and their combination on oxidative stress, inflammation, impaired angiogenesis and atherogenesis in myocardial infarction in rats.
Topics: Animals; Atherosclerosis; Cardiotonic Agents; Drug Therapy, Combination; Dyslipidemias; Inflammation | 2013 |
VLDL from Metabolic Syndrome Individuals Enhanced Lipid Accumulation in Atria with Association of Susceptibility to Atrial Fibrillation.
Topics: Adult; Animals; Apoptosis; Atrial Fibrillation; Cardiac Output; Cardiotonic Agents; Diastole; Diseas | 2016 |
Protective Effects of 7-Hydroxycoumarin on Dyslipidemia and Cardiac Hypertrophy in Isoproterenol-Induced Myocardial Infarction in Rats.
Topics: Adrenergic beta-Agonists; Animals; Cardiomegaly; Dyslipidemias; Hydroxymethylglutaryl CoA Reductases | 2016 |
Increased leptin storage with altered leptin secretion from adipocytes of rats with sucrose-induced dyslipidemia and insulin resistance: effect of dietary fish oil.
Topics: Adipocytes; Adipose Tissue, White; Adrenergic beta-Agonists; Animals; Body Weight; Cell Count; Cell | 2010 |
Beneficial role of spironolactone, telmisartan and their combination on isoproterenol-induced cardiac hypertrophy.
Topics: Adrenergic beta-Agonists; Algorithms; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazol | 2012 |
Protective effects of sinapic acid on cardiac hypertrophy, dyslipidaemia and altered electrocardiogram in isoproterenol-induced myocardial infarcted rats.
Topics: Animals; Antioxidants; Cardiomegaly; Coumaric Acids; Dyslipidemias; Electrocardiography; Hydroxymeth | 2013 |